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http://www.biomedcentral.com/1471-2180/14/163RESEARCH ARTICLE Open AccessBdellovibrio bacteriovorus HD100 guards against
Pseudomonas tolaasii brown-blotch lesions on
the surface of post-harvest Agaricus bisporus
supermarket mushrooms
Emma B Saxon1, Robert W Jackson2, Shobita Bhumbra1, Tim Smith1 and R Elizabeth Sockett1*Abstract
Background: Pseudomonas tolaasii is a problematic pathogen of cultured mushrooms, forming dark brown
‘blotches’ on mushroom surfaces and causing spoilage during crop growth and post-harvest . Treating P. tolaasii
infection is difficult, as other, commensal bacterial species such as Pseudomonas putida are necessary for mushroom
growth, so treatments must be relatively specific.
Results: We have found that P. tolaasii is susceptible to predation in vitro by the δ-proteobacterium Bdellovibrio
bacteriovorus. This effect also occurred in funga, where B. bacteriovorus was administered to post-harvest mushroom
caps before and after administration of the P. tolaasii pathogen. A significant, visible improvement in blotch
appearance, after incubation, was observed on administration of Bdellovibrio. A significant reduction in viable
P. tolaasii cell numbers, recovered from the mushroom tissue, was detected. This was accompanied by a more
marked reduction in blotch severity on Bdellovibrio administration. We found that there was in some cases an
accompanying overgrowth of presumed-commensal, non-Pseudomonas bacteria on post-harvest mushroom
caps after Bdellovibrio-treatment. These bacteria were identified (by 16SrRNA gene sequencing) as Enterobacter
species, which were seemingly resistant to predation. We visualised predatory interactions occuring between
B. bacteriovorus and P. tolaasii on the post-harvest mushroom cap surface by Scanning Electron Microscopy,
seeing predatory invasion of P. tolaasii by B. bacteriovorus in funga. This anti-P. tolaasii effect worked well in
post-harvest supermarket mushrooms, thus Bdellovibrio was not affected by any pre-treatment of mushrooms
for commercial/consumer purposes.
Conclusions: The soil-dwelling B. bacteriovorus HD100 preys upon and kills P. tolaasii, on mushroom surfaces,
and could therefore be applied to prevent spoilage in post-harvest situations where mushrooms are stored
and packaged for sale.Background
Pseudomonas tolaasii is a Gram-negative, naturally soil-
dwelling bacterial pathogen that causes brown blotch dis-
ease in several varieties of cultivated mushrooms [1-3].
The disease is characterised by brown lesions on the outer
layers (2–3 mm depth) of the mushroom pileus and stipe,
which range from small, light brown spots to larger, dark,
sunken and wet lesions, depending on disease severity.* Correspondence: liz.sockett@nottingham.ac.uk
1Genetics, School of Life Sciences, University of Nottingham, Medical School,
Queen’s Medical Centre, Nottingham NG7 2UH, UK
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unless otherwise stated.This brown discolouration results from mushroom pro-
duction of melanin, which is a defence response induced
in this case by P. tolaasii producing the toxin tolaasin.
Tolaasin is an 18-amino acid lipodepsipeptidide that
forms ion channels and also acts as a biosurfactant to dis-
rupt the plasma membrane of mushroom cells, allowing
P. tolaasii access to cell-nutrients [4-7]. Infection is also
reported to result in slower development of the mush-
room crop with a lower yield [8]. The economic im-
pact of the disease is significant, resulting in loss of visual
appeal to consumers and regular crop reductions of
5–10% in the UK [9]. The disease is found worldwide:td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in several countries, including the USA, Spain, Serbia,
the Netherlands, Japan and Korea [1,2,10-13].
A major obstacle in the control of P. tolaasii infection
that contributes to its broad prevalence is that some of
the bacterial species present in the casing soil around
mushrooms, such as Pseudomonas putida, are necessary
for promoting the initial stages of mushroom growth
[14,15]. This means that the casing soil cannot be sterile,
and broad range antibiotic and antiseptic treatments can-
not be used in the mushroom-growing process; conse-
quently, P. tolaasii may become endemic in the casing soil
and compost used in mushroom cultivation [16].
P. tolaasii survives well in nutrient-poor environments,
such as the casing soil prior to mushroom growth, by
altering the production of various enzymes, thus switch-
ing between pathogenic non-fluorescent (Smooth colony
morphology on King’s Medium B agar, S-type) and non-
pathogenic fluorescent (Rough colony morphology,
R-type) forms [17,18]. P. tolaasii also uses flagellar-
mediated chemotaxis in the wet casing soil to move to-
wards nutrient ‘signals’ produced by the mushroom; once
on the pileus surface, they attach and initiate disease rap-
idly [5,19]. Symptoms can appear on mushrooms at all
stages of development; some apparently unaffected mush-
rooms also develop symptoms after harvesting, making it
difficult to immediately identify and target P. tolaasii in-
fections [20]. Furthermore, the pathogen is spread easily
on the hands of mushroom pickers, and epidemics can
occur between multiple mushroom houses [8].
Due to the adaptability and persistence of P. tolaasii,
and the limitations on treatment options, there are very
few effective methods for controlling P. tolaasii infection
that are also safe to use on crops intended for human
consumption. The current best methods of disease pre-
vention are addition of chlorinated compounds such as
calcium hypochlorite to irrigation water, and careful con-
trol of growth conditions; for example, the surface mois-
ture of mushrooms and water level in the casing soil to
minimize P. tolaasii chemotaxis and motility; however,
the success of disease prevention is highly variable, and
not guaranteed [8,13,21].Other disinfectants and anti-
biotic compounds such as chloramine T and bronopol
have been suggested as potential treatments [13,22],
as well as natural plant extracts from Salvia miltiorrhiza
[23], and the White Line Inducing Principle (WLIP)
produced by Pseudomonas reactans, which reacts with
tolaasin produced by P. tolaasii [24]. Other Pseudo-
monads that are antagonistic to P. tolaasii, such as
Pseudomonas flourescens, have also been investigated
as biocontrol strains [25]. Most recently, the applica-
tion of a P. tolaasii-specific bacteriophage has been
proposed as a novel method of controlling P. tolaasii
infection [26], but to our knowledge none of thesealternative disease prevention methods have been tested
or used commercially.
The Gram-negative predatory bacterium Bdellovibrio
bacteriovorus has been discussed as a potential ‘living
antibiotic’ for bacterial pathogens of humans and ani-
mals. Bdellovibrio attach to, invade and replicate inside
diverse Gram-negative bacterial prey, killing the prey cell
in the process (For more detail, see [27,28]). Bdellovibrio
was isolated from soil, and thus evolved to kill bacterial
prey in soil and water [29]. It is highly motile in liquid,
using flagellar swimming [30], and it also ‘glides’ slowly
on solid surfaces [31], and uses chemotaxis to locate
regions rich in prey [32]. Despite thus being an ideal
candidate for the treatment of crop pathogens, the in-
fluence of Bdellovibrio predation on Gram-negative dis-
ease outbreaks in the soil environment remains largely
unknown. The effect of Bdellovibrio on Gram-negative
bacterial pathogen populations has previously been stud-
ied in live chickens and on soybean plant leaves rubbed
into scratches made artificially on leaf tissue [33,34]. The
supply of Bdellovibrio bacteriovorus HD100 orally to live
chickens showed that, while they did reduce pathogen
numbers and alter the gut microbiota, there were not any
harmful effects of ingestion of Bdellovibrio, which is im-
portant in a food-related setting [33].
In this current study, we investigated whether Bdello-
vibrio can be used to control the soil-borne mushroom
pathogen P. tolaasii in the natural environment of the
surface of the cultivated button mushroom Agaricus
bisporus post-harvest. We measured the effect of Bdello-
vibrio bacteriovorus HD100 application on the extent
of brown blotch lesion symptoms resulting from Pseudo-
monas tolaasii 2192T inoculation onto mushroom pilei,
and compared these with P. tolaasii cell counts re-
covered from inoculated mushrooms. We also moni-
tored the interaction between B. bacteriovorus HD100
and P. tolaasii 2192T on the mushroom pileus surface
to confirm Bdellovibrio predation of the pathogen in
funga. Bacterial-fungal interactions have been the sub-
ject of recent reviews [35] as they involve interesting
cross kingdom biology, but also affect crop productivity
and thus global food security. In this study, a bacterial-
bacterial interaction on a fungal surface prevents a patho-
genic bacterial-mushroom interaction through an active,
predatory process, rather than displacement by competi-
tion, which is the first time this has been documented.
Results
Bdellovibrio inhibits P. tolaasii population growth in vitro
To begin to test Bdellovibrio as a possible biocontrol
agent against P. tolaasii, we first aimed to assess the
impact of their co-incubation on P. tolaasii survival
in vitro. As Figure 1 shows, The Optical Density
(OD600nm) of P. tolaasii 2192
T samples in the presence
Figure 1 Reduction in P. tolaasii OD600nm over 24 hours, in vitro, in the presence of Bdellovibrio bacteriovorus. Mean OD600nm of
P. tolaasii 2192T samples in the absence or presence of live B bacteriovorus HD100 added at 4 × 106 or 1.6 × 107 Plaque Forming Units
(PFU) (n = 4). The increase in OD600nm in the absence of Bdellovibrio indicates P. tolaasii 2192
T growth, while no increase in the presence of 4 × 106 or
1.6 × 107 B. bacteriovorus HD100 indicates inhibition of P. tolaasii 2192T growth. Error bars indicate 95% Confidence Intervals for each OD600nm value.
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to a heat-killed B. bacteriovorus HD100 control, measured
over 24 hours in the BMG plate-reader. (Bdellovibrio cells
alone are too small to produce an OD600nm reading). In
the presence of B. bacteriovorus HD100 at both 4 × 106
cells/well and 1.6 × 107 cells/well, the OD600nm of P.
tolaasii 2192T did not increase from the starting value
(OD600nm = 0.05, 9.7 × 106 CFU/well) over 24 hours.
However, when live B. bacteriovorus HD100 were
substituted with heat-killed B. bacteriovorus HD100, the
OD600nm value increased from 0.08 to a final value of
0.89, corresponding to an increase from 1.6 × 107 to 1.7 ×
108 CFU over 24 hours, (n = 3, Figure 1). This indi-
cates that Bdellovibrio effectively suppressed the popula-
tion growth of P. tolaasii, most likely due to killing by
predation.Figure 2 Lesion intensity on P. tolaasii-inoculated mushrooms in th
mushroom pilei under 5 different treatment conditions, detailed to the
1.7 × 106 CFU, and each B. bacteriovorus HD100 inoculation contained 2
brown blotch disease symptoms and therefore a higher level of P. tola
intensity value for each treatment group. Student’s t-test of significance b
inoculated with P. tolaasii 2192T: **p < 0.01, ***p <0.001.Brown blotch lesion intensity was reduced by Bdellovibrio
application onto mushrooms
Given B. bacteriovorus HD100 was observed to suppress
P. tolaasii 2192T growth in vitro, we reasoned that this
effect might be replicated in a more natural environ-
ment. We first aimed to determine whether symptoms
of P. tolaasii infection, a function of bacterial metabol-
ism and growth, were reduced with Bdellovibrio treat-
ment in a natural context. The intensity of lesions
formed by P. tolaasii 2192T on the post-harvest pileus
surface of the cultivated button mushroom Agaricus bis-
porus was measured in the presence and absence of
B. bacteriovorus HD100, as shown in Figure 2. Mush-
room pilei inoculated with P. tolaasii 2192T alone, in the
absence of any treatment with B. bacteriovorus HD100,
formed dark, wet surface lesions, the primary symptom ofe presence and absence of Bdellovibrio. Lesion intensities on
right of the graph. Each P tolaasii 2192T inoculation contained
.9 × 106 PFU. Higher lesion intensity indicates a greater level of
asii infection. Horizontal black bars indicate the mean lesion
etween B. bacteriovorus HD100 treated and non-treated mushrooms
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sity = 0.019 1/PV ± 0.0005, n = 30). In contrast, pilei
treated with a King’s Medium B control (the preferred
growth medium of P. tolaasii) did not form these dark le-
sions (mean intensity = 0.012 1/PV ± 0.0005, n = 30); simi-
larly, those treated with B. bacteriovorus HD100 alone,
and not inoculated with P. tolaasii 2192T, also did not
form dark lesions (mean intensity = 0.010 1/PV ± 0.0005,
n = 30), so Bdellovibrio application itself did not have
a significant adverse effect on the appearance of mush-
room pilei.
Post-harvest mushrooms treated with B. bacteriovorus
HD100 either 30 minutes before or 30 minutes after
P. tolaasii 2192T inoculation developed significantly
lighter lesions than those inoculated with P. tolaasii
2192T alone (average intensity = 0.015 and 0.016 1/PV ±
0.0005 respectively, n = 30 in both cases, vs. 0.019 1/PV ±
0.0005 for mushrooms inoculated with P. tolaasii 2192T
alone). This demonstrates that Bdellovibrio effectively
reduces the dark lesions of brown blotch disease caused
by P. tolaasii, and that this reduction is slightly greater
where Bdellovibrio is added before P. tolaasii. The sig-
nificance of the difference in lesion intensities be-
tween B. bacteriovorus HD100 treated and untreated,
P. tolaasii 2192T inoculated mushrooms was greater
when Bdellovibrio was added before P. tolaasii 2192T
than when added after (Student’s t-test p < 0.001 for
B. bacteriovorus HD100 added before P. tolaasii 2192T
vs. P. tolaasii 2192T alone, p < 0.01 for B. bacteriovorus
HD100 added after P. tolaasii 2192T vs. P. tolaasii 2192T
alone). Bdellovibrio application may therefore be more ef-
fective as a preventative measure to protect mushrooms
against brown blotch disease, rather than a treatment for
an already infected mushroom crop, and could be ex-
plored as a background addition to mushroom compost
or casing layers to maintain “health”.
Scanning Electron Microscope images show
B. bacteriovorus attachment and bdelloplast formation
in P. tolaasii cells
To confirm whether the reduction in P. tolaasii 2192T
numbers and brown blotch lesion intensity was due to
B. bacteriovorus HD100 predation in funga or another com-
petition for resources, the interaction between P. tolaasii
and Bdellovibrio was monitored in samples from the sur-
face of the post-harvest A. bisporus (shown untreated in
Figure 3a), 48 hours after mushroom treatments, using
Scanning Electron Microscopy (SEM). P. tolaasii 2192T
added alone to the mushroom pileus accumulated to-
gether, in an arrangement parallel to the pileus surface, in
the pits present between chitin fibres (Figure 3b). Fibrillar
structures attached to the P. tolaasii 2192T cells were
frequently observed, which have also been documented in
previous microscopic studies [36]. These resemble pili,with extracellular polymeric substances laid down on
them, and may allow P. tolaasii to adhere tightly to the
mushroom surface and to each other in a biofilm, to rapidly
initiate disease (Figure 3b [37]). B. bacteriovorus HD100
added alone to the mushroom surface survived after
48 hours and also accumulated in the small pits between
chitin fibres (Figure 3c).
Where B. bacteriovorus HD100 was added to the mush-
room surface both before (Figure 3e) and after P. tolaasii
2192T (Figure 3d), B. bacteriovorus HD100 attachment to
P. tolaasii 2192T cells was observed: a crucial first step in
the predatory process. In addition, bdelloplasts, the rounded,
dead P. tolaasii structures in which Bdellovibrio establish,
grow and replicate after attachment and invasion, were
also observed where B. bacteriovorus HD100 was added
before or after P. tolaasii 2192T. Although a valid statis-
tical survey is not possible in these SEM samples, bdello-
plasts were most clearly visible on the mushroom surface
where B. bacteriovorus HD100 was added before P. tolaa-
sii 2192T (Figure 3d). This correlates with the greater re-
duction in lesion intensity measurements on mushrooms
where B. bacteriovorus HD100 was added before P. tolaa-
sii 2192T (Figure 2): Bdellovibrio attachment to prey and
subsequent bdelloplast formation may be easier, and occur
more rapidly, where P. tolaasii cells have not had time to
accumulate, adapt and adhere to the mushroom surface,
preventing P. tolaasii from producing as much tolaasin,
and thus reducing the extent of the characteristic brown
blotch symptoms.
A King’s Medium B control addition to the pileus re-
sulted in the growth of different types of bacterial cells,
with different morphologies that were distinct from that
of P. tolaasii 2192T & B. bacteriovorus HD100 (Figure 3f);
however, typically, no bacterial cells were observed on un-
treated mushroom tissue (Figure 3a). This indicates that
the supermarket mushrooms carry a small, indigenous
bacterial microflora that replicates readily in added growth
medium, which may impact upon P. tolaasii CFU num-
bers recovered from experimentally inoculated tissue, as
described below.
Application of Bdellovibrio before inoculation with
P. tolaasii reduced the number of P. tolaasii in infected
mushroom tissue
To determine whether the reduction in lesion intensity
after treatment with B. bacteriovorus HD100 correlated
with a reduction in P. tolaasii 2192T cell numbers,
CFU were recovered and enumerated from mushroom
tissue that had been inoculated with P. tolaasii 2192T
and pre-treated with B. bacteriovorus HD100, com-
pared with a P. tolaasii 2192T inoculated, non-B. bacter-
iovorus HD100 treated control (Figure 4). A mean
number of 4.5 × 107 and 3.9 × 107 CFU were recovered
from mushrooms pre-treated with 2.9 × 106 or 1.4 × 107
Figure 3 Predatory interactions between Bdellovibrio and P. tolaasii “in funga” on the mushroom pileus surface. Scanning Electron
Microscope images showing the mushroom pileus surface 48 hours after the following treatments: a. untreated mushroom pileus surface
b. inoculation of P. tolaasii 2192T alone c. Inoculation of B. bacteriovorus HD100 alone d. and e. Co-inoculation of P. tolaasii 2192T and
B. bacteriovorus HD100 and f. Application of King’s medium B alone. In image e, B. bacteriovorus HD100 (blue) are shown attached at one
pole to P. tolaasii 2192T (yellow), a crucial first step in the predatory process. Images d and e both show rounded P. tolaasii 2192T cells,
characteristic of the bdelloplast structures formed after Bdellovibrio invades the host cell and begins replication. 1 μm scale bar shown.
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were both significantly lower than the mean 1.9 × 108 CFU
recovered from mushrooms inoculated with P. tolaasii
2192T alone (Student’s t-test of difference p < 0.05);
these observations correlated with a significant reduc-
tion in lesion intensity (p < 0.001) on mushrooms
treated with 2.9 × 106 and 1.4 × 107 PFU B. bacterio-
vorus HD100 (mean = 0.010 1/PV in both cases) com-
pared with mushrooms inoculated with P. tolaasii
2192T alone (mean = 0.014 1/PV). Despite this signifi-
cant reduction in lesion intensity, the total number of
CFU recovered from B. bacteriovorus HD100 treated
mushrooms onto King’s Medium B was high, suggest-
ing that the bacteria recovered from seemingly simi-
lar, beige-coloured colonies on the King’s Medium B
plates were not solely pathogenic P. tolaasii 2192T,
but might include other species indigenous to the
mushroom pileus surface that are not well preyed
upon by B. bacteriovorus HD100, as observed in SEM
images of mushroom tissue to which King’s medium
B broth was added alone.Enterobacter species are present on the surface of some
commercially produced supermarket mushrooms
The number of CFU recovered from the mushrooms
that were treated with B. bacteriovorus HD100 after in-
oculation with P. tolaasii was relatively high compared
to mushrooms inoculated with P. tolaasii alone. To con-
firm the identity of the bacteria seen in Figures 3d and e
and recovered from supermarket mushroom tissue pre-
treated with B. bacteriovorus HD100 before P. tolaasii
2192T at both 2.9 × 106 and 1.4 × 107 PFU ml−1, 20 col-
onies taken from the King’s medium B agar plates used
to enumerate bacterial CFU, recovered from the treated
mushroom tissue of two mushrooms in each group,
were grown on Coliform Chromogenic agar (oxoid).
This agar contains two chromogenic substrates that turn
purple when cleaved by the enzymes glucorinidase and
galactosidase, which are both present in coliforms such
as E. coli, and absent from Pseudomonads (including
P. tolaasii); all 20 colonies were pigmented purple in-
dicating them as coliform, closely related to E. coli,
and therefore as indigenous species to the mushroom
Figure 4 Bacterial CFU numbers recovered from P. tolaasii-inoculated mushrooms in the presence and absence of Bdellovibrio.
Lesion intensities and number of bacterial colony forming units (CFU) recovered from mushroom pilei subject to three different treatments detailed to
the right. Each P. tolaasii 2192T inoculation contained 1.7 × 106 CFU. Images of mushrooms with typical: high, mean, and low intensity lesions in each
group are shown below the graph. Horizontal black bars indicate the mean values for lesion intensity/CFU count in each treatment group. Student’s
t-test of significance between B .bacteriovorus-treated and non-treated mushrooms inoculated with P. tolaasii 2192T: *p <0.05, ***p <0.001.
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produced straw coloured colonies on the agar. Three of
these coliform isolates were identified by 16 s rDNA
sequencing as members of the Enterobacter genus using
the BLAST online tool (http://blast.ncbi.nlm.nih.gov/Blast.
cgi), which showed that the isolates were most closely
related to Enterobacter sp. LB9 (GenBank: JQ864377.1)
matching 99% identity. This explains the relatively high
number of total bacterial colonies recovered from mush-
room tissue treated with Bdellovibrio, despite the re-
duction in the dark lesions characteristic of P. tolaasii
infection: Bdellovibrio predation rapidly reduces P. tolaasii
population numbers on the mushroom surface, but does
not necessarily reduce those of other non-disease causing,
likely mushroom-indigenous species, such as the Entero-
bacter isolated in this study. The King’s Medium B in
which P. tolaasii 2192T and B. bacteriovorus HD100 were
added to the surface of the mushroom during test inocula-
tions, and the cell-lysate debris left behind after P. tolaasii
death due to predation, may then allow these indigenous
Enterobacter to occupy the niche caused by Bdellovibrio
predation of P. tolaasii.
Discussion
We showed that B. bacteriovorus HD100 is a predator of
P. tolaasii 2192T in vitro and in vivo (in funga), suppressingpopulation growth of the strain over a 24-hour period
where 4 × 106 or 1.6 × 107 PFU B. bacteriovorus HD100
were added to pathogen on post-harvest mushrooms
(Figures 1 and 4). P. tolaasii is a difficult pathogen to
control in mushroom grow-houses due to its ability to
persist in nutrient-poor soils and the ease with which it
spreads through mushroom compost, through flagellar
swimming, and via the hands of pickers during the manual
harvesting process [8]. Furthermore, commensal bacterial
species in the mushroom casing soil play a key role in
mushroom growth initiation, and therefore any treatment
to prevent or treat P. tolaasii infection must not result in
a completely sterile growth environment, which may re-
sult from broad antibiotic or antiseptic treatment. Thus it
is beneficial to explore post-harvest anti- P. tolaasii treat-
ments, such as this study with B. bacteriovorus.
Our SEM images confirmed that B. bacteriovorus HD100
survived on the post-harvest supermarket mushroom
surfaces after 48 hours, and was therefore unaffected
by any pre-treatment of those mushrooms for commer-
cial purposes to promote growth and extend shelf-life in
the film-covered plastic trays they were sold in (Figure 3c).
B. bacteriovorus is therefore a viable treatment for bacter-
ial diseases of mushrooms, such as brown blotch disease.
Previous studies of mushroom infections have found that
a ‘threshold’ number of P. tolaasii cells are required for
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tolaasin, the chemical mediator of the brown blotch symp-
tom development [8]. We found that when B. bacterio-
vorus HD100 was applied to the surface of post-harvest,
commercially grown mushrooms before or after inocula-
tion with P. tolaasii, both the intensity of the brown blotch
symptoms of disease and the number of P. tolaasii 2192T
present the mushroom surface were significantly reduced
(Figures 2 and 4), supporting the threshold hypothesis.
Our SEM images also showed that B. bacteriovorus HD100
attached to, invaded and killed P. tolaasii 2192T cells by
forming bdelloplasts on the pileus surface, when added
both before or after P. tolaasii 2192T inoculation (Figure 3d
and e); thus, reduction in P. tolaasii 2192T numbers
and disease symptoms was due to predatory activity by
B. bacteriovorus HD100. As the consumer preference is
for white, clean-looking mushrooms with minimal sur-
face damage, the reduction in brown blotch tissue dam-
age by B. bacteriovorus application could increase the
yield and possibly the shelf life of high-quality, market-
able mushrooms. This study investigated the survival
of B. bacteriovorus HD100 and its predatory activity
against P. tolaasii on the surface of post-harvest mush-
rooms up to 48 hours, sufficient time for brown blotch
disease to develop on untreated mushrooms. Thus studies
over longer time points, covering time from transporta-
tion to the sell-by date, would need to be investigated, in
future work, if Bdellovibrio was to be applied as a treat-
ment to extend shelf-life.
In addition to reducing the population of P. tolaasii
on the mushroom surface, Bdellovibrio are natural soil
dwellers and so their application to casing soil could also
prevent spread of brown blotch between mushrooms in
the growth environment and between grow houses. In
this way, the fast swimming motility of Bdellovibrio [38]
would allow efficient location of P. tolaasii prey, using
chemotaxis, in the wet casing soil prior to mushroom
growth initiation, and translocation by gliding along the
mushroom pileus surface after mushroom fruiting bodies
have formed, preventing P. tolaasii infection establish-
ment at multiple stages of mushroom growth; previously,
the possibility of infection throughout the mushroom
growth period has been an obstacle in brown blotch dis-
ease control. Further pre-harvest studies could investigate
the longevity and protective effect of Bdellovibrio inocu-
lated into the casing soil around mushroom mycelium,
before and after fruiting body initiation, on growing
A. bisporus. As Bdellovibrio preys efficiently upon some,
but not all, species of Pseudomonas (unpublished observa-
tions), and some Pseudomonads in the casing soil such as
P. putida are important in fruiting body initiation; further
studies would additionally investigate the predatory activ-
ity of B. bacteriovorus HD100 against such commensal
strains in vitro and in the casing soil to ensure that thereare no effects that would have an adverse impact on mush-
room fruiting body production.
As host-dependent Bdellovibrio require prey cells to
survive, the post-harvest treatment could also be self-
limiting, as Bdellovibrio would die once P. tolaasii prey
had been eradicated; further studies could quantify this.
Furthermore, these in vitro and in vivo predation studies
suggest that B. bacteriovorus may be able to survive the
action of the toxins produced by P. tolaasii and other
members of the Pseudomonas genus, including tolaasin
and other lipases and peptidases, which cause the dam-
age to the mushroom pileus [39]. This suggests that
Bdellovibrio species may be effective against other crop
pathogenic bacterial species, even if they produce biologic-
ally active secreted compounds. This could be followed up
with studies of the pure compounds themselves versus
B. bacteriovorus.
We infrequently isolated Enterobacter species in our
experiments from supermarket mushrooms, likely being
commensals growing in number after pre-treatment with
B. bacteriovorus HD100, suggesting that these Entero-
bacter isolates are not susceptible to Bdellovibrio predation.
A Plant Growth Promoting (PGP) Enterobacter species,
Enterobacter cloacae, has been described previously,
which colonises rice root surfaces and competes with
other species in the soil microbiota for nutrients [40].
Enterobacter species have also previously been iso-
lated from spent mushroom compost [41], where they
might associate with the mushroom surface in a simi-
lar way, competing with other mushroom-indigenous
bacteria as commensal species. As Bdellovibrio has previ-
ously been shown to prey upon diverse Enterobacter
species [42], it was unexpected that numbers seemed
unaffected by Bdellovibrio predation; inhibition of preda-
tion in this case may be due to a factor such as the
presence of a protective S-layer, which may prevent
Bdellovibrio from attaching to and invading Entero-
bacter prey cells [43], but confirming S-layer presence
was beyond the scope of this study. The Enterobacter
species in this study were isolated from Bdellovibrio-
treated mushroom tissue, unaffected by any brown blotch
disease symptoms; and so the species are unlikely to be
pathogenic, and may be commensals. It could therefore be
beneficial that Bdellovibrio are unable to prey upon the
Enterobacter species isolated in this study, preserving any
beneficial commensal effect they might have, while still
protecting against P. tolaasii infection.
Conclusions
Bdellovibrio bacteriovorus HD100 are terrestrial bac-
teria which show natural control of Pseudomonas tolaa-
sii, a spoilage pathogen of mushroom crops, on the
non-sterile, biotic surface of the mushroom pileus.
These terrestrial bacteria therefore have a natural ability
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crop pathogens.
Methods
The bacterial strains and primers used in this study are
listed in Tables 1 and 2, respectively.
Bacterial culturing procedures
E. coli S17-1 was grown in YT medium (5 g/L Sodium
Chloride, 5 g/L Peptone, 8 g/L Tryptone, pH 7.5) shaken
at 200 rpm at 37°C for 16 hours. The predatory, host-
dependent B. bacteriovorus HD100 was cultured at 29°C
on E. coli S17-1 prey cells on YPSC medium agar
(0.125 g/L Magnesium Sulphate, 0.25 g/L Sodium Acetate,
0.5 g/L Bacto Peptone, 0.5 g/L Yeast Extract, 0.25 g/L
Calcium Chloride Dihydrate, pH 7.6) using an overlay
plate technique. Liquid predatory cultures of B. bacterio-
vorusHD100 for predation tests were produced by 16 hour
incubation at 29°C in 2 mM CaCl2 25 mM HEPES
pH 7.6 buffer, containing E. coli S17-1 prey, both
methods described in detail elsewhere [30]. Following
growth the B. bacteriovorus HD100 were filtered by
passage twice through Millipore 0.45 μm syringe fil-
ters to remove any remaining prey. P. tolaasii 2192T was
grown in King’s Medium B (Prepared using Scientific
Laboratory Supplies Bacto™ Proteose Peptone No. 3,
product code 221693, according to the UNE-EN
12780 standard protocol, Cat. No. 1154) at 29°C for
16 hours. When isolating indigenous bacteria from
mushrooms Coliform chromogenic agar (Oxoid, prod-
uct code CM0956) was used, again with incubation at
29°C.
B. bacteriovorus predation of P. tolaasii populations
grown in vitro
B. bacteriovorus predation of P. tolaasii was firstly tested
in a buffer-Pseudomonas King’s medium B suspension in
a plate reader. 180 μl/well of a 50% v/v King’s Medium
B, 50% v/v 2 mM CaCl2 25 mM HEPES pH 7.6 buffer
mixture was added to the wells of a clear-bottomed, 96-
well Krystal microplate (Porvair Sciences Ltd, Product
No. 215006). 1.5 ml aliquots of predatory cultures of B.
bacteriovorus HD100, containing 2.5 × 108 PFU ml−1,
were prepared and heat killed at 105°C for 5 minutes
and allowed to cool to ambient temperature (21°C). This
heat-killed, cooled culture was then added, in a 3:1 ratio,Table 1 Bacterial strains used in this study
Strain Descripti
Escherichia coli S17-1 (used as prey to initially culture Bdellovibrio) thi, pro, h
Bdellovibrio bacteriovorus HD100 Type strai
Pseudomonas tolaasii 2192T Type strai
acquiredto a live liquid culture of B. bacteriovorus HD100 to give
6.3 × 107 PFU ml−1 of live B. bacteriovorus HD100. This
was used as a diluted application of Bdellovibrio to
achieve a lowered concentration of predator in our ex-
periments. Microplate wells were then set up using ei-
ther 64 μl of the heat-killed culture alone as a negative
control; 64 μl of the heat-killed/live mixture described
above; or 64 μl of the original live culture of Bdellovibrio.
These preparations gave final live B. bacteriovorus HD100
cell numbers of 0, 4 × 106 or 1.6 × 107 PFU, respectively.
For test prey cells, a liquid culture of P. tolaasii 2192T,
containing 7.4 × 108 CFU/ml−1, was diluted 2 in 5 to give
3.0 × 108 CFU/ml−1 in 50% v/v King’s Medium B, 50% v/v
2 mM CaCl2 25 mM HEPES pH 7.6 buffer mixture. 20 μl
of this diluted P. tolaasii 2192T containing 5.9 × 106 CFU
was transferred to the microplates containing the predator
mixtures. The plates were then sealed with a Breatheasy®
seal (Diversified Biotech Cat. No. BEM-1) and transferred
to a BMG plate reader programmed to incubate and
measure the OD600nm of each well, as an indicator of
P. tolaasii 2192T growth, immediately, and then every
30 minutes for 24 hours. B. bacteriovorus HD100 alone
does not produce an OD600nm value due to its small cell
size [48].
Testing the effect of B. bacteriovorus predation of
P. tolaasii on brown blotch lesion intensity on infected
mushrooms
Button mushrooms (Agaricus bisporus) used in this ex-
periment were sourced from a supermarket and thus were
from a non-sterile setting. Wearing gloves to avoid hand
contamination, mushrooms were gently wiped clean with
laboratory tissue to remove any attached compost and ex-
cess surface moisture, but allow the mushroom epidermis
to remain intact. Stipes were trimmed flat with a sterile
scalpel blade, and each mushroom was placed, pileus side
up, in a sterile 50 ml skirted Falcon tube. Bacterial prepa-
rations were grown in liquid culture as before, but con-
centrated before use, by centrifugation in Falcon tubes at
5200 rpm, 20 min at 25°C in a Sigma 4 K15 centrifuge
and resuspension in King’s Medium B to the appropriate
concentration (which was checked by viable counting after
the experiments). (The P. tolaasii 2192T produced only
beige smooth colonies on the King’s Medium B, after
24 hour incubation at 29°C.) Concentrations used in the
15 μl applications to the mushrooms were as follows:on Reference
sdR−, hsdM+, recA, integrated plasmid RP4-Tc::Mu-Kn::Tn7 [44]
n, genome sequenced [29,45]
n, NCPPB No. 2192T, brown blotch pathogen of mushrooms,
from RW Jackson (University of Reading)
[46]
Table 2 Primers used in this study
Name Sequence Description
16 s_8F AGAGTTTGATCMTGGC ‘Universal’ forward primer designed to amplify/sequence diverse bacterial 16 s rDNA sequences [47]
16 s_1492rev TACCTTGTTAYGACTT ‘Universal’ reverse primer designed to amplify/sequence diverse bacterial 16 s rDNA sequences [47]
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15 μl−1), B. bacteriovorus HD100 (2.9 × 106 Plaque-
Forming Units, PFU, 15 μl−1) and King’s Medium B were
applied directly to the mushroom pileus in one of 5 pair-
wise combinations for the experiment in Figure 2 (see
Table 3 below). In later experiments other concentrations
of bacteria were used as described.
Mushrooms were incubated statically at 29°C, in capped
Falcon tubes for 48 hours, after which brown blotch le-
sions appeared on P. tolaasii 2192T infected samples. Le-
sions were photographed using a Canon PowerShot A620
digital camera and tripod in a containment hood, with the
same standard lighting for each photograph. The aperture
was set to F = 5.6 and shutter speed was set to 1/60 sec, to
give a good light exposure (±0 Exposure Value units). The
lesion intensity on each mushroom was analysed using
ImageJ analysis software (http://rsbweb.nih.gov/ij/): Image
J converted each image to 8-bit grayscale, assigning a value
of 0–255 to each pixel; the area of mushroom inoculated
was selected and the average grayscale value for each pixel
(the Pixel Value, PV), was calculated. On this scale, 0 =
black and 255 = white, and so the data were transformed
using the formula 1/PV to invert the scale, so that darker
lesions give higher intensity values. These transformed
data are displayed in Figures 2 and 4.
Visualising B. bacteriovorus and P. tolaasii interactions on
the mushroom surface
Mushrooms under each of the five treatment conditions
detailed in Table 3 were visualised using Scanning Electron
Microscopy. Preparation of mushroom samples for im-
aging was as follows: Samples of mushroom pileus surface
tissue W 5 mm× L 5 mm×D 2 mm were cut and stored
in 70% ethanol. They were then dehydrated through a
graded series of ethanol concentrations (fresh 70% etha-
nol, followed by 90% ethanol, and finally 2 changes of
100% ethanol) and dried using a Polaron E3000 CriticalTable 3 Treatment conditions applied to mushroom pilei
Condition Addition 1 (in 15 μl)
King’s Medium B control King’s Medium B broth
B. bacteriovorus alone B. bacteriovorus HD100
P. tolaasii alone P. tolaasii 2192T
B. bacteriovorus before P. tolaasii B. bacteriovorus HD100
B. bacteriovorus after P. tolaasii P. tolaasii 2192T
Details of the 5 pairwise combinations of B. bacteriovorus HD100, P. tolaasii 2192T a
of B. bacteriovorus predation of P. tolaasii on affected mushroom brown blotch lesioPoint Dryer. The dried samples were mounted onto alu-
minium stubs using silver paint, and the stubs were gold
coated (~10 μm thickness) using a Polaron E5100 SEM
Coating Unit. The samples were viewed and photographed
under a JEOL JSM 840 Scanning Electron Microscope
at 20 kV. Images were false-coloured in Adobe Photoshop
by selecting P. tolaasii 2192T and B. bacteriovorus
HD100 cells and using the ‘Colorize’ function in the
‘Hue/Saturation’ tool. A pale yellow colour was selected
for P. tolaasii to provide optimum contrast to the mush-
room surface, and blue gave a sharp contrast for the
B. bacteriovorus.
Enumerating P. tolaasii recovered from infected
mushroom tissue
Mushrooms were pre-treated using methods as above;
B. bacteriovorus HD100 was applied at either 2.9 × 106 or
1.4 × 107 PFU 15 μl−1 before 1.7 × 106 P. tolaasii 2192T in
15 μl. Mushroom lesions were photographed in a class II
containment hood after 48 hours, as above, and lesion in-
tensities were analysed using ImageJ analysis software. Le-
sion tissue from each mushroom was then cut out using a
sterile scalpel blade. Tissue samples were weighed and
homogenised in sterile 2 mM CaCl2 25 mM HEPES pH 7.6
buffer (1 ml Calcium HEPES/0.04 g lesion tissue) using sep-
arate glass pestle and mortar sets, (pre-cleaned with ethanol
and dried), for samples under each of the different treat-
ment combinations. P. tolaasii 2192T CFU recovered from
each sample were enumerated by serial dilution and plating
on King’s Medium B agar, incubated at 29°C for 15 hours.
Characteristic smooth, beige colonies growing on King’s
Medium B were counted and recorded as P. tolaasii.
Identifying bacterial species co-isolated from some
experimentally infected supermarket mushroom tissue
When King’s Medium B plates were examined and
counted to enumerate P. tolaasii 2192T from one batch30 min, 21˚C Addition 2 (in 15 μl) 48 h, 29°C
→ King’s Medium B broth →
→ King’s Medium B broth →
→ King’s Medium B broth →
→ P. tolaasii 2192T →
→ B. bacteriovorus HD100 →
nd King’s Medium B added to Agaricus bisporus mushrooms to test the effect
n intensity.
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tively high number of bacterial colonies, some of which
were small and clumped together on the King’s B medium
enumeration plates, were recovered from P. tolaasii
2192T inoculated mushroom tissue pre-treated with B.
bacteriovorus HD100 compared with tissue inoculated
with P. tolaasii 2192T alone. This suggested that other,
possibly indigenous, bacteria were present, in addition to
the added P. tolaasii 2192T and B. bacteriovorus HD100.
To test this, 20 single colonies were selected from the
small clumped colonies recovered from mushroom tissue
pre-treated with B. bacteriovorus HD100 at both 2.9 × 106
and 1.4 × 107 PFU ml−1 (taken from two mushrooms from
each group). These were plated directly onto Coliform
chromogenic agar (CCA) (Oxoid) and incubated at 29°C
for 15 hours, along with a P. tolaasii 2192T control, to dis-
tinguish between Pseudomonads and Coliforms. All of
these small, clumped colonies were purple on CCA, indi-
cating a different identity to P. tolaasii 2192T, which gave
straw-coloured colonies on CCA. Total genomic DNA
from each of 3 purple coliform isolates (hereafter referred
to as Supermarket Mushroom Isolates 1, 2 and 3) was ex-
tracted using a Sigma DNA extraction kit and ‘universal’
16 s ribosomal DNA primers (Table 2) were used in PCR
reactions to amplify 16 s rDNA sequences which were se-
quenced by Source Bioscience Life Sciences, using the
same primers. The resulting sequences were used to iden-
tify the closest match to the 16 s rDNA sequences of the
isolates using the BLAST online tool, http://blast.ncbi.
nlm.nih.gov/Blast.cgi.
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